Literature DB >> 2668961

Influence of Mycobacterium leprae and its soluble products on the cutaneous responsiveness of leprosy patients to antigen and recombinant interleukin 2.

G Kaplan1, E P Sampaio, G P Walsh, R A Burkhardt, T T Fajardo, L S Guido, A de Miranda Machado, R V Cellona, R M Abalos, E N Sarno.   

Abstract

Experiments were carried out in the skin of patients with leprosy to examine whether suppressor cell populations either exist in the skin of multibacillary lepromatous leprosy patients, can be activated with antigen, or are induced to emigrate into a cutaneous site from the circulation. For this purpose, purified protein derivative of tuberculin, a delayed-type antigen that generates a cell-mediated immune response, was introduced into the skin alone or with nonviable Mycobacterium leprae bacilli. Areas of induration and the resulting numbers and phenotypes of emigratory cells were not influenced by M. leprae and its products. Further studies examined the ability of M. leprae and its soluble products to modify the cutaneous response to intradermal injection of recombinant interleukin 2 (IL-2), a lymphokine that mimics a cell-mediated response. Neither the simultaneous injection of M. leprae and IL-2, nor the prior injection of M. leprae followed in 2 days by IL-2, nor the prior administration of IL-2 followed in 4 days by M. leprae, into the same skin site, modified the zone of induration generated by IL-2. In addition, the immunocytochemical and histopathological evaluation of biopsy specimens of skin sites showed no difference between sites injected with IL-2 and sites injected with IL-2 and M. leprae. We conclude that suppressor T cells, if they exist, do not influence the gross or microscopic responsiveness of a cell-mediated skin reaction to antigen and IL-2. IL-2 did, however, enhance the responsiveness of skin-test-positive tuberculoid patients and family contacts to M. leprae antigens by a synergistic effect on the zone of induration and local cell accumulation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2668961      PMCID: PMC297819          DOI: 10.1073/pnas.86.16.6269

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Periodate-lysine-paraformaldehyde fixative. A new fixation for immunoelectron microscopy.

Authors:  I W McLean; P K Nakane
Journal:  J Histochem Cytochem       Date:  1974-12       Impact factor: 2.479

2.  Activated suppressor T cells in leprosy.

Authors:  V Mehra; J Convit; A Rubinstein; B R Bloom
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

3.  Studies of a human T lymphocyte antigen recognized by a monoclonal antibody.

Authors:  E G Engleman; R Warnke; R I Fox; J Dilley; C J Benike; R Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

4.  Reactivity of Langerhans cells with hybridoma antibody.

Authors:  E Fithian; P Kung; G Goldstein; M Rubenfeld; C Fenoglio; R Edelson
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

5.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

6.  Mechanism of immunosuppression in leprosy: presence of suppressor factor(s) from macrophages of lepromatous patients.

Authors:  P R Salgame; P R Mahadevan; N H Antia
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

7.  Thymus-dependent membrane antigens in man: inhibition of cell-mediated lympholysis by monoclonal antibodies to TH2 antigen.

Authors:  R L Evans; D W Wall; C D Platsoucas; F P Siegal; S M Fikrig; C M Testa; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

8.  The generation of antigen-specific, major histocompatibility complex-restricted cytotoxic T lymphocytes of the CD4+ phenotype. Enhancement by the cutaneous administration of interleukin 2.

Authors:  G E Hancock; Z A Cohn; G Kaplan
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

9.  Delineation of a human T cell subset responsible for lepromin-induced suppression in leprosy patients.

Authors:  V Mehra; L H Mason; W Rothman; E Reinherz; S F Schlossman; B R Bloom
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

10.  Production of a suppressor factor by human adherent cells treated with mycobacteria.

Authors:  A A Wadee; R Sher; A R Rabson
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

View more
  5 in total

1.  Suppression of T-cell proliferation by Mycobacterium leprae and its products: the role of lipopolysaccharide.

Authors:  A Molloy; G Gaudernack; W R Levis; Z A Cohn; G Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

2.  T-cell-mediated cytotoxicity against Mycobacterium antigen-pulsed autologous macrophages in leprosy patients.

Authors:  M C Sasiain; S de la Barrera; F Minnucci; R Valdez; M M de Elizalde de Bracco; L M Baliña
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

Review 3.  Current concepts in the pathogenesis of leprosy. Clinical, pathological, immunological and chemotherapeutic aspects.

Authors:  W M Meyers; A M Marty
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

4.  Cutaneous response to recombinant interleukin 2 in human immunodeficiency virus 1-seropositive individuals.

Authors:  M J McElrath; G Kaplan; R A Burkhardt; Z A Cohn
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

5.  Zanvil Alexander Cohn 1926-1993.

Authors:  R M Steinman; C L Moberg
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.